Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-04

Clinical Trial Update: Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial updating rates of symptom relief and relapse prevention during esomeprazole therapy for erosive esophagitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole (Esomeprazole)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Erosive Esophagitis | Phase 4 | Status: COMPLETED | Results posted: 2018-09-04